Company Information
Industry 制造业
Company Introduction 浙江本立科技股份有限公司是国家高新技术企业,专注于化工中间体领域,致力医药中间体、农药中间体、新材料中间体的研发、生产和销售,始终坚持以创新为驱动,针对化工中间体行业应用领域存在的痛点和难点,开发安全、环保和经济的合成工艺以替代传统工艺,是国内专业的专注于清洁生产的化工中间体生产企业。在研发与技术服务能力、稳定供货能力、品牌影响力等方面拥有较强的竞争优势。公司研发能力突出,自主创新能力较强,拥有多项专利及非专利技术,其中发明专利24项、实用新型专利10余项,承担多项重大科研项目。2016年相继荣获“浙江省科技进步一等奖”、“中国石油和化工联合会科技进步一等奖”、“中国产学研创新合作成果一等奖”等荣誉。 公司聚焦喹诺酮原料药及关键中间体绿色工艺路线的研究,创设了一氧化碳羰基化反应、四氯化碳傅克反应和喹诺酮原料药绿色合成等技术平台,实现801产品和1201产品等关键中间体产业化,并通过上述关键中间体把部分喹诺酮原料药的生产工艺统一到一个大平台上,有效解决了有毒、有害原料使用量大、“三废”产生量多、生产成本高等行业问题,为喹诺酮原料药及关键中间体规模化、循环化、连续化和自动化生产创造了条件。 公司801产品和1201产品先后单独或共同应用到氧氟沙星、左氧氟沙星、环丙沙星、恩诺沙星和诺氟沙星等十多个喹诺酮原料药,随着工艺替代的延伸,后续将应用到更多喹诺酮原料药。除医药中间体的应用外,公司还将801产品的应用拓展到农药中间体领域,并利用三大技术平台,成功研发部分农药中间体和新材料中间体的新生产工艺,替代和改造传统工艺,开始进入农药杀菌剂、杀虫剂、除草剂以及新材料的光引发剂、医药头孢等领域,产品和技术应用领域逐渐扩大。 十余年来,本立科技践行“君子务本,本立而道生”的企业精神,秉承“创新、替代和成本”的经营理念,以为行业提供价廉物美的化工中间体为己任,实施差异化战略,以创新工艺替代传统工艺,围绕三大技术平台,选择医药、农药、新材料等领域部分产品及其关键中间体生产工艺进行替代和改造,不断扩大产品及技术的应用领域,进一步延伸产业链,建立持续创新机制,保持旺盛的创新活力,通过新工艺、新产品与产业深度融合,不断扩大公司规模和提升公司盈利能力,为发展企业、成就员工、服务客户、回馈社会而不懈奋斗。
Main Business 医药中间体、农药中间体、新材料中间体的研发、生产和销售。
Legal Representative 吴政杰
Top Executives
董事长:吴政杰
董事:罗臣,潘凯宏
执行董事:吴政杰
独立董事:赵新建,王宝庆,周华俐
Top 5 Shareholder
Shareholder name Nature Holding Date
吴政杰限售股+流通A股24.18%31/03/2026
陈建军流通A股10.10%31/03/2026
台州少思投资合伙企业(有限合伙)流通A股7.43%31/03/2026
顾海宁流通A股6.04%31/03/2026
蒋华江流通A股5.05%31/03/2026
Company Secretary 王佳佳
Solicitors 上海市锦天城律师事务所
Auditors 立信会计师事务所(特殊普通合伙)
Tel No 0576-85501188
Fax No 0576-85585230
Website www.benlitech.com
Email blkj@benlitech.com
Company Address
Register: 浙江省临海头门港新区东海第六大道15号
Office: 浙江省临海头门港新区东海第六大道15号
Listing Date 14/09/2021
Shares Capital
Shares Capital: 106,020,000
Total A Share: 106,020,000
Listed A Share: 86,287,500
Non-tradable A Share: 19,732,500
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.760
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 12.923
Market Capitalization(RMB) 1.797B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.